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Abstract
Myeloid cell leukemia sequence 1 (Mcl-1), an antiapoptotic member of the Bcl-2 family, is often overexpressed in
tumor cells limiting the therapeutic success. Mcl-1 differs from other Bcl-2 members by its high turnover rate. Its
expression level is tightly regulated by ubiquitylating and deubiquitylating enzymes. Interaction of Mcl-1 with cer-
tain Bcl-2 homology domain 3 (BH3)–only members of the Bcl-2 family can limit the access to Mcl-1 ubiquitin ligase
E3 and stabilizes the antiapoptotic protein. In addition, the overexpression of the deubiquitinase ubiquitin-specific
protease 9x (USP9x) can result in the accumulation of Mcl-1 by removing poly-ubiquitin chains fromMcl-1 preventing
its proteasomal degradation. Analyzing radiation-induced apoptosis in Jurkat cells, we found that Mcl-1 was down-
regulated more efficiently in sensitive parental cells than in a resistant subclone. The decline of Mcl-1 correlated with
cell death induction and clonogenic survival. Knockdown of BH3-only proteins Bim, Puma, and Noxa did not affect
Mcl-1 level or radiation-induced apoptosis. However, ionizing radiation resulted in activation of USP9x and enhanced
deubiquitination of Mcl-1 in the radioresistant cells preventing fast Mcl-1 degradation. USP9x knockdown enhanced
radiation-induced decrease of Mcl-1 and sensitized the radioresistant cells to apoptosis induction, whereas USP9x
knockdown alone did not changeMcl-1 level in unirradiated cells. Together, our results indicate that radiation-induced
activation of USP9x inhibits Mcl-1 degradation and apoptosis resulting in increased radioresistance.
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Introduction
The success of many antineoplastic therapies is based on a thorough
removal of tumor cells through induction of apoptosis. Ionizing radia-
tion that is commonly used in anticancer therapies and many cytotoxic
drugs, e.g., anthracyclines, induces cell death through the mitochondrial
pathway that is controlled by the Bcl-2 protein family. The family is
subdivided into an antiapoptotic group consisting of Bcl-2 itself,
Bcl-xL, and myeloid cell leukemia sequence 1 (Mcl-1) among others
and a proapoptotic group. The latter comprises the multidomain pro-
teins Bax, Bak, and Bok, as well as several Bcl-2 homology domain 3
(BH3)–only containing proteins [1]. The antiapoptotic members
maintain mitochondrial integrity, prevent the release of proapoptotic
factors from the intermembrane space into the cytosol and the sub-
sequent caspase activation. In addition, the protective Bcl-2, Bcl-xL,
andMcl-1 are overexpressed in diverse tumors and constitute resistance
factors that prevent a successful antitumor therapy [2,3]. Therefore,
understanding the regulatory mechanisms of the antiapoptotic proteins
is crucial for the success of future therapies.
The antiapoptotic proteins can interact with the BH3 domain of
proapoptotic Bcl-2 members to neutralize each other [4]. Although
all antiapoptotic Bcl-2 family members exhibit redundant protective
function, they cannot always substitute each other [5–7]. Moreover,
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the protective proteins are regulated by distinct mechanisms at the
transcriptional, translational, and posttranslational levels [8–10].
In contrast to Bcl-2 and Bcl-xL, Mcl-1 is a short-lived protein with
a high turnover rate. Shutdown of protein translation results in a
rapid decline [10]. Sequestration by BH3-only proteins and phos-
phorylation reportedly regulate Mcl-1 degradation [11–15]. Inter-
estingly, different kinases can have opposite effect on the turnover
of Mcl-1. Whereas phosphorylation by extracellular regulated kinases 1
and 2 (ERK1/2) at threonine 163 slows Mcl-1 protein turnover, phos-
phorylation at serine 159 by glycogen synthase kinase-3β (GSK-3β) tar-
gets Mcl-1 for ubiquitylation and proteasomal degradation [12,14].
The transfer of ubiquitin moieties is catalyzed by ubiquitin ligases.
So far, three ubiquitin ligases targeting Mcl-1 were identified, namely,
Mcl-1 ubiquitin ligase E3 (Mule), β-transducin repeat–containing
protein (β-TrCP), and FBW7 [16–19]. β-TrCP and FBW7 are
the Mcl-1–recognizing components of the Skip/Collin/F-box ubiquitin
ligase complex. Previous publications indicate that phosphorylation
of Mcl-1 accelerates β-TrCP– or FBW7-dependent degradation
of the antiapoptotic protein [16,18]. The single peptide ligase Mule,
in contrast, contains a BH3-like domain through which the en-
zyme interacts with Mcl-1 similar to the complex formed by Mcl-1
with other BH3-only proteins [19]. Consequently, Noxa—and proba-
bly also Bim and Puma—can limit the access of Mule and Mule-
dependent degradation of Mcl-1 while interacting with the antiapoptotic
protein [13,15].
The ubiquitylation can be reversed by deubiquitinases. Recently,
the deubiquitinase ubiquitin-specific protease 9x (USP9x) was de-
scribed to remove poly-ubiquitin chains from Mcl-1, thereby stabi-
lizing the protective protein and increasing resistance to apoptosis
induced by the Bcl-2/Bcl-xL inhibitor ABT-737 [20]. Increased
USP9x expression correlates with Mcl-1 protein levels in human fol-
licular and diffuse large B-cell lymphomas and is associated with poor
prognosis for patients with multiple myeloma [20].
Despite the growing knowledge about the mechanisms control-
ling Mcl-1 stability, little is known how Mcl-1 levels are regulated
in response to ionizing radiation (IR). Using Jurkat T lymphoma
cells, we analyzed the sensitivity of two clones to IR-induced apop-
tosis. The sensitive cells died faster and exhibited a lower clono-
genic survival upon irradiation than the resistant cells. In both
clones, the radiosensitivity correlated with IR-induced Mcl-1 de-
cline, and the reduction of Mcl-1 levels was prerequisite for apop-
tosis induction. Thus, the ability to maintain high Mcl-1 levels for
a much longer time might explain the reduced radiosensitivity of
the resistant cell clone. Interestingly, inhibition of GSK-3β could not
prevent Mcl-1 degradation, suggesting that the kinase does not reg-
ulate Mcl-1 stability. To further analyze the mechanism controlling
Mcl-1 turnover, BH3-only proteins Bim, Puma, and Noxa and the
deubiquitinase USP9x were silenced by siRNA. However, knock-
down of none of the BH3-only proteins affected the Mcl-1 level or
IR-induced apoptosis.
IR induced activation of USP9x in resistant Jurkat cells 24 hours
after irradiation. This activation coincided with an enhanced interac-
tion between USP9x andMcl-1 and enhanced Mcl-1 deubiquitylation.
Accordingly, knockdown of USP9x accelerated the radiation-induced
Mcl-1 degradation and sensitized the radioresistant Jurkat subclone
and another tumor cell line, the radioresistant K562 chronic myeloge-
nous leukemia cells, to apoptosis. We conclude that radioresistance can
be acquired by activation of USP9x that stabilizes Mcl-1 protein levels
and increases cell survival.
Materials and Methods
Reagents and Antibodies
Pan-caspase inhibitor zVAD-fmk was purchased from Bachem
(Bubendorf, Switzerland), cycloheximide from Sigma (Deisenhofen,
Germany), GSK-3 inhibitor XV and MG132 from Calbiochem
(Merck, Darmstadt, Germany), and WP1130 from Selleck Chemicals
(Munich, Germany).
The following antibodies were used for Western blot analysis and
immunoprecipitation: mouse anti–caspase-9 and rabbit anti-Bak from
Upstate (Millipore, Schwalbach, Germany), rabbit anti–caspase-3, poly
(ADP ribose) polymerase (PARP), Mcl-1, Bcl-xL, β-catenin, GSK-3β,
phospho–GSK-3β (S21/9), Akt, phospho-Akt (S473) and phospho-
Akt (T308), and mouse anti-ubiquitin (clone P4D1) from Cell Sig-
naling (NEB, Frankfurt, Germany), rabbit anti-Puma and Bim from
Epitomics (Biomol, Hamburg, Germany), mouse anti–Bcl-2 from Santa
Cruz Biotechnology (Heidelberg, Germany), mouse anti-Noxa from
Calbiochem (Merck), rabbit anti-USP9x from Novus Biologicals and
mouse anti-USP9x from Abnova (both distributed by Acris, Heford,
Germany), mouse anti–Mcl-1 from Pharmingen (Becton Dickinson,
Heidelberg, Germany), mouse anti–glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) from Abcam (Cambridge, United Kingdom),
and mouse anti–β-actin from Sigma.
Cells and Cell Culture
Jurkat E6 T lymphoma cells ( Jurkat-sensitive) and K562 chronic
myelogenous leukemia cells were from ATCC (Bethesda, MD). The
radioresistant Jurkat subclone emerged after a prolonged cell culture.
Cells were grown in RPMI 1640 medium supplemented with 10%
fetal calf serum (Gibco Life Technologies, Eggenstein, Germany) and
maintained in a humidified incubator at 37°C and 5% CO2.
Transfection with siRNA
Cells were cultured at a low density to ensure log phase growth.
For transfection, 3 × 106 cells were resuspended in 300 μl of RPMI-
1640 without phenol red. After adding siRNA at indicated concen-
trations, Jurkat cells were electroporated at 370 V for 10 ms and
K562 cells at 340 V for 5 ms, using an EPI2500 electroporator
(Fischer, Heidelberg, Germany). Immediately after transfection, cells
were resuspended in prewarmed medium and continued to be cul-
tured as described above. Transfection efficiency and viability were
determined by transfecting the cells with 400-nM green fluorescence
siGLO siRNA followed by propidium iodide exclusion dye and flow
cytometric analysis. Mcl-1, Puma, Bim, Noxa, USP9x ON-TARGET
SMARTpools, siCONTROL NON-TARGETING pool, and siGLO
siRNA were purchased from Dharmacon (Chicago, IL).
Flow Cytometric Analysis
The mitochondrial membrane potential (ΔΨm) was analyzed using
the ΔΨm-specific dye tetramethylrhodamine ethyl ester (Molecular
Probes, Mobitech, Goettingen, Germany). At the indicated time
points, cells were stained for 30 minutes in phosphate-buffered saline
(PBS) containing 25 nM tetramethylrhodamine ethyl ester. To ex-
amine DNA fragmentation, we incubated cells with PBS containing
0.1% Triton X-100 and 10 μg/ml propidium iodide. Short-term sur-
vival was measured employing a propidium iodide exclusion dye.
The cells were incubated with PBS containing 10 μg/ml propidium
iodide in the absence of any detergent. Cells were detected in channel 2
employing a FACS Calibur flow cytometer (Becton Dickinson) and
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analyzed with the FCS Express 3 software (De Novo Software,
Los Angeles, CA). Data show mean values ± SD of at least six
independent experiments.
Clonogenic Test
Clonogenic survival was analyzed as described before [21]. In
brief, cells were seeded at different dilutions and irradiated with
0 to 8 Gy. For each dilution, the amount of wells that shows a re-
population 4 weeks after irradiation was counted. Using the Origin
6.0 software (Microcal Inc., Northampton, MA), the amount of cells
that was needed to repopulate 50% of the wells (WC50) was calcu-
lated. The surviving fraction (SF) was calculated by normalizing the
WC50 values of irradiated cells to the WC50 values of the respective
nonirradiated control cells. The error of SF was calculated by error
propagation according to Gauss.
Western Blot Analysis
Cells were lysed in 200 μl of lysis buffer containing 50 mM Hepes
(pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10 mM
sodium pyrophosphate, 10 mMNaF, 2 mMNa3VO4, 100 mM PMSF,
5 μg/ml aprotinin, 5 μg/ml leupeptin, and 3 μg/ml pepstatin. Protein
was separated by sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE) under reducing conditions and transferred
onto polyvinylidene fluoride (PVDF) membranes (Roth, Karlsruhe,
Germany). Blots were blocked in TBS buffer containing 0.05% Tween
20 and 5% nonfat dry milk for 1 hour at room temperature. The
membrane was incubated overnight at 4°C with the respective primary
antibodies. The secondary antibody was incubated for 1 hour at room
temperature. Detection of antibody binding was performed by en-
hanced chemiluminescence (ECL Western Blotting Analysis System;
GE Healthcare/Amersham Biosciences, Freiburg, Germany). Equal
loading was verified by antibodies against GAPDH or β-actin. Where
indicated, protein levels were quantified by densitometry using the
ImageJ software (ImageJ 1.40g, National Institutes of Health, Bethesda,
MD). All Western blot experiments were repeated at least once.
Immunoprecipitation
Cells were lysed as described above using 1% CHAPS as deter-
gent. The protein concentration was adjusted to 2 mg/ml. Two
micrograms of anti-USP9x antibody (Novus Biologicals) or 10 μl of
anti–Mcl-1 antibody (Cell Signaling) and 50 μl of slurry Dynabeads
suspension (Dynal/Invitrogen, Karlsruhe, Germany) were added to
750 μl of lysate. After precipitation for 3 hours at 4°C, the beads
were washed thrice with 300 μl of lysis buffer containing 0.2%
of the respective detergent. Proteins were eluted by boiling the
beads for 10 minutes in 100 μl of SDS sample buffer containing
2.5% β-mercaptoethanol. Thirty microliters of the eluate was sep-
arated by SDS-PAGE before transfer to PVDF membrane and detec-
tion by chemiluminescence as described above. Immunoprecipitations
were repeated at least once.
Ubiquitin-7-amino-4-methylcoumarin (AMC) Assay
Cells were lysed in DUB buffer [20 mMHepes (pH 7.5), 150 mM
NaCl, 0.5% NP-40, and 5 mMMgCl2]. Five hundred micrograms of
protein was precipitated with 1 μg of rabbit anti-USP9x antibody as
described above. Washed beads were suspended in 100 μl of DUB
buffer. The reaction was started by adding 500 nM ubiquitin-AMC
and detected with a Tecan microplate reader (Infinite 200, Tecan,
Mainz, Germany) using excitation at 380 nm and emission at 460 nm.
Six independent experiments were performed. Data represent mean
values ± SD.
USP9x–Mcl-1 Assay
IR-resistant cells were irradiated with 0 or 10 Gy or treated with
5 μM MG132. Twenty-four hours after irradiation, cells were lysed
in buffer containing 20 mM Hepes (pH 7.5), 150 mM NaCl, 1%
CHAPS, and 5 mM MgCl2. USP9x was precipitated as described
above. Alternatively, cells treated with MG132 were lysed and Mcl-1
was precipitated from the lysates as described above. The precipitates
were washed three times with a buffer containing 20 mM Hepes
(pH 7.5), 150 mM NaCl, 0.2% CHAPS, and 5 mM MgCl2 and
resuspended in 20 μl of washing buffer additionally containing 50 μl
of dithiothreitol (DTT). The precipitated Mcl-1 was added to the
USP9x precipitates and incubated for 30 minutes at 37°C. Where
indicated, USP9x activity was inhibited by adding 5 μM WP1130
before uniting with precipitated Mcl-1. Afterward, precipitates were
separated by SDS-PAGE under reducing conditions and analyzed by
Western blot using antibodies against ubiquitin, Mcl-1, and USP9x.
Mcl-1 Degradation Assay
Cells were treated with 1 μM cycloheximide for 0, 0.5, 1, 2, and
3 hours. At indicated time points, cells were lysed and lysates were
separated as described above. Mcl-1 protein levels were detected by
Western blot analysis. Several Western blots were made from the
same lysates. Protein levels were quantified by densitometry using
ImageJ software (ImageJ 1.40g, National Institutes of Health).
Monoexponential decay was fitted using Origin 6.0 software and
normalized as described in the legend.
Data Analysis
Statistical significance was calculated by a one-way analysis of
variance (ANOVA) test using GraphPad Software (San Diego, CA).
Results
Effective Down-regulation of Mcl-1 Correlates with
Radiosensitivity in Jurkat Lymphoma Cells
To analyze resistance mechanisms that prevent apoptosis induc-
tion in response to IR, we irradiated two clones of Jurkat T lymphoma
cells with 10 Gy. Dissipation of the mitochondrial membrane poten-
tial (ΔΨm) and DNA degradation (sub-G1 population) were analyzed
by flow cytometry (Figure 1, A–D). The clones differ in their sensi-
tivity to radiation-induced apoptosis. ΔΨm dissipation and DNA deg-
radation occurred more efficiently in the IR-sensitive parental clone
than in the IR-resistant subclone (Figure 1, A–D).
Furthermore, short-term survival upon irradiation with 10 Gy was
analyzed employing a propidium iodide exclusion dye (Figure 1E ),
whereas long-term survival was examined by clonogenic assay using
limiting cell dilutions to calculate the SF (Figure 1F ). Both assays
showed that the short-term as well as the long-term survival was lower
in the IR-sensitive cells. The activation of the initiator caspase-9, the
executioner caspase-3, and cleavage of caspase-3 substrate PARP were
impaired in the resistant cells after irradiation (Figure 1G ). The levels
of the antiapoptotic Bcl-2 and Bcl-xL, as well as of the proapoptotic
Bcl-2 family members Bak and Bim, remained unchanged in both cell
clones. However, levels of the antiapoptotic Mcl-1 visibly decreased in
the IR-sensitive cells, whereas levels of the specific Mcl-1 interacting
BH3-only protein Noxa were unaffected (Figure 1G ).
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To clarify the importance of Mcl-1 down-regulation for mitochon-
drial permeabilization and apoptosis induction, we electroporated
nontargeting (nt) or Mcl-1–targeting (mcl1) siRNA into both clones.
Mcl-1 levels were reduced by the specific siRNA already 3 hours after
electroporation and not detectable 3 more hours later (Figure 2A).
Consistent with Mcl-1 decline, ΔΨm dissipated within 6 hours after
electroporation (Figure 2B), indicating the pivotal function of Mcl-1
in maintenance of mitochondrial homeostasis and cell survival in both
Jurkat clones.
GSK-3β Does Not Control Mcl-1 Stability in Jurkat Cells
Because Mcl-1 is essential for Jurkat cell survival, we set out to
analyze the mechanisms regulating its protein levels. Mcl-1 function
and stability can be controlled by BH3-only proteins, by kinases like
GSK-3β, by ubiquitin ligases facilitating proteasomal degradation,
and by deubiquitinases preventing proteasomal degradation.
First, we analyzed the regulation of Mcl-1 by GSK-3β. The kinase
GSK-3β is inactive when phosphorylated by PKB/Akt, thus unable to
phosphorylate and destabilize Mcl-1. Interestingly, IR had no impact
on phospho-Akt and phospho–GSK-3β in Jurkat cells, even though
Mcl-1 and β-catenin levels decreased (Figure 3A). To test whether
GSK-3β influences radiation-induced apoptosis, we treated IR-sensitive
cells with 30 nM GSK-3 inhibitor XV when irradiated with 10 Gy.
Treatment with GSK-3 inhibitor XV resulted in an accumulation
of the GSK-3β target β-catenin without changing Mcl-1 levels or IR-
induced Mcl-1 decline (Figure 3B). Flow cytometric analysis showed
that ΔΨm dissipation (Figure 3C) and DNA degradation (Figure 3D)
occurred to the same extent in inhibitor- or vehicle-treated cells.
Figure 1. IR-induced down-regulation of Mcl-1 and apoptosis induction are impaired in resistant Jurkat subclone. Sensitive (IR-sensitive)
and resistant (IR-resistant) Jurkat cells were irradiated with 10 Gy. ΔΨm dissipation (A, C), DNA degradation (B, D), and survival (E) were
analyzed by flow cytometry at indicated time points after irradiation. (A) Representative histograms show cells with intact (ΔΨm-H for
high ΔΨm) and dissipated (ΔΨm-L for low ΔΨm) mitochondrial membrane potential 24 hours after irradiation. (B) Representative histo-
grams display cells with degraded DNA visualized in the sub-G1 fraction 48 hours after irradiation. Results of ΔΨm dissipation and DNA
fragmentation are shown in C and D, respectively (n = 6, mean ± SD). Radiation-induced ΔΨm dissipation and DNA fragmentation were
significantly reduced in IR-resistant cells. (E) Cell death and survival were quantified by flow cytometry employing a propidium iodide
exclusion dye (n = 8, mean ± SD). (F) Long-term survival was analyzed in a clonogenic assay using limiting dilutions of the IR-resistant
and IR-sensitive cells. The SF was calculated for cells irradiated with 0, 2, 4, 6, and 8 Gy (normalized to respective nonirradiated cells).
Error bars of SF are within the symbols. (G) Western blot analysis shows cleavage of caspase-9, caspase-3, and the caspase-3 substrate
PARP in sensitive cells in response to IR, which is abrogated in resistant cells. Down-regulation of Mcl-1 and Puma levels are detected in
IR-sensitive cells only. Levels of other Bcl-2 proteins (Bcl-xL, Bcl-2, Bak, Bim, and Noxa) were not affected by irradiation. GAPDH was
used as loading control. ***P < .001.
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Furthermore, phosphorylation of Mcl-1 could not be detected in
irradiated or nonirradiated Jurkat cells (Figure W1B). From those
experiments, we conclude that the PKB/Akt–GSK-3β pathway does
not regulate Mcl-1 levels in Jurkat cells.
BH3-only Proteins Are Not Involved in Mcl-1 Stability
Our next focus was on those BH3-only proteins, which are known
interaction partners of Mcl-1. Bim, Puma, and Noxa were described
to be upregulated in response to irradiation. In our cell system, how-
ever, Bim and Noxa levels remained unchanged (Figure 1G ), whereas
Puma levels decreased 24 hours after irradiation in IR-sensitive cells.
Cotreatment of those cells with the pan-caspase inhibitor zVAD
abrogated the decline of Puma but not of Mcl-1 (Figure 4A), indicating
that change of Puma levels occurred in the executive phase of apoptosis
after caspase activation, whereas Mcl-1 was downregulated before
caspases became activated (Figures 1G and 4A).
The association of the BH3-only proteins with Mcl-1 might change
during radiation-induced apoptosis independent of their protein levels.
We, therefore, silenced the expression of Bim, Puma, andNoxa by siRNA
in the sensitive clone. Down-regulation of respective proteins was verified
by Western blot analysis 72 hours after electroporation (Figure 4, B–D,
upper panels). Two days after electroporation, cells were irradiated with
10 Gy. ΔΨm dissipation (Figure 4, B–D, middle panels) and DNA deg-
radation (Figure 4, B–D, lower panels) were analyzed 24 and 48 hours
after irradiation, respectively. Surprisingly, silencing of Bim, Puma, or
Noxa did not alter Mcl-1 protein levels, radiation-induced ΔΨm dis-
sipation, and DNA degradation. The results indicate that none of the
three BH3-only proteins regulates radioresistance in the Jurkat cells.
USP9x Controls Mcl-1 Stability in Jurkat Lymphoma Cells
In previous publications, USP9x was shown to interact with Mcl-1
and β-catenin [20,22]. Both proteins were downregulated only in
Figure 3. GSK-3β does not regulate Mcl-1 stability in irradiated Jurkat cells. (A) IR-sensitive Jurkat cells were irradiated with 10 Gy. Cells
were lysed 24 hours after irradiation. Western blot analysis shows that phopsho–GSK-3β levels were not changed by IR, whereas the
levels of GSK-3β substrates Mcl-1 and β-catenin were clearly reduced. (B–D) IR-sensitive Jurkat cells were irradiated with 10 Gy in the
presence of 30 nM GSK-3 inhibitor XV. (B) Twenty-four hours later, cells were lysed and analyzed by Western blot. Treatment of IR-
sensitive Jurkat cells with 30 nM GSK-3 inhibitor XV for 24 hours resulted in an accumulation of β-catenin without having an effect
on Mcl-1 levels. GSK-3 inhibitor XV did not alter a radiation-induced Mcl-1 decline. Dissipation of mitochondrial membrane potential
(ΔΨm) was analyzed by flow cytometry 24 hours after irradiation. (D) DNA fragmentation was analyzed by flow cytometry 48 hours after
irradiation. GSK-3 inhibitor XV had no effect on radiation-induced ΔΨm dissipation or DNA degradation. Flow cytometric data show
means ± SD (n = 6); NS indicates no significance (P > .05).
Figure 2. Mcl-1 prevents mitochondrial permeabilization in IR-
sensitive and IR-resistant cells. Mcl-1 siRNA (mcl1; 500 nM) or
nontargeting siRNA (nt) was electroporated into IR-sensitive and
IR-resistant Jurkat cells. (A) Three and six hours after electroporation,
lysates were made, and down-regulation of Mcl-1 was analyzed by
Western blot analysis. GAPDH was used as loading control. (B) Six
hours after electroporation, dissipation of mitochondrial membrane
potential (ΔΨm low) was analyzed by flow cytometry. In both IR-
sensitive and IR-resistant cells, the expression of Mcl-1 is essential
for maintaining mitochondrial homeostasis. ***P < .001.
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IR-sensitive but not in IR-resistant cells after irradiation (Figure 5A).
In contrast, USP9x levels were not changed in both, IR-sensitive and
IR-resistant cells, in response to IR. However, USP9x, when activated,
might specifically enhance its affinity to Mcl-1 and remove the ubiqui-
tin chains from Mcl-1, thereby stabilizing the antiapoptotic protein in
IR-resistant cells. To test this hypothesis, we precipitated Mcl-1 from
IR-sensitive and IR-resistant cells before and 24 hours after irradiation
with 10 Gy. Much more USP9x coprecipitated with Mcl-1 in irradi-
ated resistant cells than in the nonirradiated control cells (Figure 5B).
On the contrary, this radiation-induced increased association of
USP9x and Mcl-1 could not be detected in IR-sensitive cells.
To test whether the half-life time of Mcl-1 was altered in irradiated
cells, IR-sensitive and IR-resistant cells were treated with 1 μM cyclo-
heximide 24 hours after irradiation with 10 Gy. Densitometric analysis
of Mcl-1 levels in Western blot shows that, in response to IR, Mcl-1
half-life time was greatly decreased in sensitive cells but not in resistant
cells (Figure 5, C–E). This indicates that an enhanced degradation rate
accelerates Mcl-1 decline in IR-sensitive cells following irradiation.
An enhanced association of USP9x with Mcl-1 does not necessarily
reflect an enhanced USP9x enzymatic activity. Thus, we performed
a fluorometric activity assay following precipitation of USP9x from
irradiated and nonirradiated control cells. Notably, a significant
increase of USP9x activity could be detected only in IR-resistant
but not in IR-sensitive cells 24 hours after irradiation (Figure 6A).
Using a pan–phospho-serine/threonine antibody, we also detected an
IR-induced phosphorylation of USP9x, which was markedly higher
in the IR-resistant than in IR-sensitive cells indicating a posttranslational
modification in response to IR (Figure W1A).
Moreover, when adding purified ubiquitylated Mcl-1 to precipi-
tated USP9x, we could detect a decrease of ubiquitylated, high mo-
lecular Mcl-1 and an accumulation of p40Mcl-1, indicating an Mcl-1
deubiquitylation byUSP9x following irradiation.Mcl-1 deubiquitylation
was much more pronounced when incubated with USP9x precipitated
from irradiated IR-resistant cells compared with USP9x precipitated from
nonirradiated IR-resistant cells (Figure 6B, left and middle lane). Inhibi-
tion of USP9x activity by WP1130 (5 μM) prevented deubiquitylation
of Mcl-1 in irradiated IR-resistant cells (Figure 6B, right lane).
In addition, analysis of ubiquitylated protein by Western blot fol-
lowing Mcl-1 precipitation shows less ubiquitylated, high molecular
Mcl-1 in IR-resistant cell 24 hours after irradiation than in nonirradiated
Figure 4. Bim, Puma, and Noxa are dispensable for radiation-induced apoptosis. (A) IR-sensitive Jurkat cells were treated with 30 μM
caspase inhibitor zVAD or the solvent only and irradiated with 10 Gy. Twenty-four hours later, cell lysates were made and analyzed by
Western blot analysis. Radiation-induced decline of Puma but not of Mcl-1 could be blocked by the caspase inhibitor, indicating that
down-regulation of Mcl-1 occurs upstream of caspase activation, whereas Puma is downregulated after caspase activation. (B) Bim
siRNA (500 nM), (C) Puma siRNA (1 μM), (D) Noxa siRNA (1 μM), or respective concentrations of nontargeting (nt) siRNA were electro-
porated into IR-sensitive Jurkat cells. Forty-eight hours later, cells were irradiated with 10 Gy. ΔΨm dissipation was examined 24 hours
after irradiation by flow cytometry (B–D, middle panels), whereas DNA fragmentation was analyzed 48 hours after irradiation (B–D, lower
panels). Data show means ± SD (n = 3); NS indicates no significance (P > .05). Down-regulation of Bim, Puma, and Noxa and Mcl-1
levels were verified by Western blot analysis 72 hours after electroporation (B and C, upper panels). The knockdown of the respective
proteins was quantified by densitometry. Abrogation of Bim, Puma, or Noxa expression did not affect radiation-induced apoptosis in
Jurkat cells.
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control cells (Figure 6C ). Such a decrease of ubiquitylated, high molec-
ular Mcl-1 was not observed in IR-sensitive cells 24 hours after irradi-
ation. Interestingly, an overall change of ubiquitylated proteins, such as
is observed 3 hours after treatment with 5 μM proteasome inhibitor
MG132, could not be detected in Jurkat cells 24 hours after irradia-
tion with 10 Gy (Figure 6D), indicating a specific regulation of Mcl-1
ubiquitylation status following irradiation.
USP9x Knockdown Sensitizes Radioresistant Cells to
IR-induced Apoptosis
The observation was also supported in the next set of experiments
in which USP9x was downregulated by siRNA. USP9x knockdown
was verified 48 hours after electroporation with 1 μM nontargeting or
USP9x-targeting siRNA. Interestingly, depletion of USP9x did not
affect Mcl-1 levels in IR-sensitive or IR-resistant cells (Figure 7A).
Forty-eight hours after electroporation, IR-sensitive and IR-resistant
cells were irradiated with 10 Gy. Twenty-four and forty-eight hours
after irradiation,ΔΨm (Figure 7B) and cellular DNA content (Figure 7C)
were analyzed by flow cytometry. USP9x knockdown slightly, but
significantly, enhanced ΔΨm dissipation and DNA degradation in
IR-sensitive cells. The increase of ΔΨm dissipation and DNA degrada-
tion was even more pronounced in the resistant subclone. In addition,
Mcl-1 levels and caspase-3 activation were analyzed by Western blot
(Figure 7D). To this end, IR-sensitive cells were lysed 24 hours and
IR-resistant cells 30 hours after irradiation. A clear down-regulation
of Mcl-1 and caspase-3 as well as PARP processing were observed in
IR-sensitive Jurkat cells 24 hours after irradiation, whereas only a weak
Mcl-1 decline and processed caspase-3 and PARP fragments were de-
tected in the IR-resistant subclone 30 hours after irradiation. Silencing
of USP9x hardly accelerated IR-induced Mcl-1 degradation and
caspase-3 processing in the IR-sensitive cells 24 hours after irradiation.
In contrast, USP9x silencing clearly accelerated the decline of Mcl-1
as well as caspase-3 activation and PARP cleavage in IR-resistant
cells 30 hours after irradiation, although Mcl-1 down-regulation and
caspase-3 activation did not reach the same extent as in the IR-sensitive
clone. To examine the effect of USP9x knockdown on Mcl-1 degrada-
tion in IR-resistant cells, the half-life time was analyzed 48 hours after
irradiation with 10 Gy (Figure 7, E–G). Although irradiation alone re-
duced slightly, but not significantly, Mcl-1 half-life, USP9x knock-
down resulted in a further significant reduction of Mcl-1 half-life.
Our results indicate that USP9x stabilizes Mcl-1 upon irradiation in
the resistant Jurkat subclone, whereas it has no effects on Mcl-1 in
nonirradiated cells.
To exclude an effect limited to our Jurkat cell model, we examined
the role of USP9x in radiation-induced apoptosis in another cell line.
Irradiation with 10 Gy hardly induced caspase-3 activation and PARP
cleavage within the first 48 hours in K562 cells, a chronic myeloge-
nous leukemia cell line (Figure 8A). A decrease of Mcl-1 levels was
observed not until 48 hours after irradiation. Therefore, hardly any
DNA fragmentation was detected until 72 hours after irradiation
(Figure 8B). Obviously, K562 cells are very refractory to radiation-
induced apoptosis. Silencing of USP9x by siRNA significantly en-
hanced DNA degradation 72 hours after irradiation (Figure 8C )
and also accelerated Mcl-1 decline as well as caspase-3 and PARP
processing (Figure 8D). Thus, the radioprotective effects of USP9x
were observed not only in radioresistant Jurkat cells but also in
Figure 5. Irradiation enhances interaction of Mcl-1 with USP9x in resistant cells and prevents Mcl-1 degradation. (A) IR-sensitive and IR-
resistant Jurkat cells were irradiated with 10 Gy. Lysates were made 4, 8, 12, and 24 hours later and analyzed by Western blot. USP9x
levels did not change in response to irradiation. The levels of potential USP9x substrates Mcl-1 and β-catenin decreased only in IR-sensitive
cells upon irradiation. Densitometric quantification of USP9x and Mcl-1 is shown below the Western blots of the respective cells. (B) IR-
sensitive and IR-resistant cells were irradiated with 10 Gy. Twenty-four hours later, Mcl-1 was precipitated from irradiated and nonirradiated
cells. More USP9x coprecipitated in irradiated IR-resistant than in IR-sensitive cells. The whole-cell lysate (WCL) shows the overall Mcl-1 and
USP9x protein levels before precipitation. (C–E) Twenty-four hours after irradiation with 10 Gy, cells were treated with 1 μM cycloheximide
(CHX) for 0 to 3 hours. Cells were lysed at respective time points. (C) Mcl-1 levels were analyzed by Western blot. (D) Mcl-1 levels were
quantified by densitometry. The values were fitted and the half-life of Mcl-1 was calculated. (E) Graph shows the mean values ± SD ofMcl-1
half-life time (n = 7). *P < .05.
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radioresistant K562 cells, indicating a more general mechanism of
radioresistance mediated by USP9x.
Taken together, our findings suggest a novel mechanism of radio-
resistance that involves the activation of the deubiquitinase USP9x and
the USP9x-dependent stabilization of Mcl-1 following irradiation.
Discussion
Failure to Downregulate Mcl-1 Mediates Radioresistance
Ionizing radiation is widely used in antitumor therapies because of
its antiproliferative and cytotoxic effects. The response to irradiation
varies profoundly between different tumors. Factors responsible for
radioresistance need to be identified and targeted to improve the ther-
apeutical outcome. The related proteins Bcl-2, Bcl-xL, and Mcl-1 are
already identified as radioresistance factors [23–27]. When over-
expressed, they prevent radiation-induced apoptosis, enhance survival,
and impair tumor response to radiotherapy. In our present study, we
focused on Mcl-1 whose stability is tightly regulated by ubiquitin
ligases and deubiquitinases. For the first time, we could show that
the deubiquitinase USP9x contributes to radioresistance by stabilizing
Mcl-1 protein levels.
To identify a molecular mechanism regulating radioresistance, we
used two Jurkat lymphoma cell clones that differ in their radiosensitivity,
which arose spontaneously after prolonged cell culture. IR-induced
apoptosis was delayed in resistant cells. In addition, short-term as well
as long-term survival was significantly lower in sensitive cells upon
radiation. Interestingly, the down-regulation of Mcl-1 protein levels
in response to IR occurred faster in sensitive cells.
Figure 6. Ionizing radiation induces activation of USP9x and deubiquitylation of Mcl-1 in IR-resistant cells. (A) IR-sensitive and IR-resistant
Jurkat cells were irradiatedwith 10Gy. Twenty-four hours after irradiation, USP9xwas precipitated from the lysates. (A) The activity of USP9x
was determined by adding a fluorogenic substrate to the precipitated USP9x. Increased USP9x activity could be detected only in resistant
cells 24 hours after irradiation. Data show mean values ± SD (n = 6); ***P < .001; NS indicates no significance (P > .05). (B) IR-resistant
Jurkat cells were irradiated with 10 Gy. Twenty-four hours after irradiation, USP9x was precipitated from the lysates of irradiated and
nonirradiated control cells. In parallel, IR-resistant cells were treated with 5 μM proteasome inhibitor MG132 for 3 hours to accumulate
ubiquitylated Mcl-1. To start the deubiquitylation reaction, we added ubiquitylated Mcl-1 precipitated from MG132-treated lysates to the
USP9x precipitated from irradiated lysates. Mcl-1 deubiquitylation was analyzed by Western blot using an antibody against ubiquitin and
Mcl-1. Where indicated by (i), USP9x activity was inhibited by adding 5 μM WP1130 before the incubation with precipitated Mcl-1. Less
ubiquitylated Mcl-1 and more p40 Mcl-1 were detected after incubation with USP9x precipitated from irradiated cells. (C) Twenty-four hours
after irradiationwith 10 Gy,Mcl-1 was precipitated from the lysates of irradiated or nonirradiated control cells. The ubiquitylation state ofMcl-1
was detected by Western blot using antibodies against ubiquitin and Mcl-1. IR-induced decrease of high molecular, ubiquitylated Mcl-1 was
detected only in IR-resistant cells 24 hours after irradiation. (D) IR-sensitive and IR-resistant Jurkat cells were either irradiated with 10 Gy (left
panel) or treated with 5 μMMG132 (right panel). Cell lysates were analyzed by Western blot. No change of ubiquitylated proteins in WCLs
was observed 24 hours after irradiation. In contrast, treatment with MG132 for 3 hours resulted in an accumulation of ubiquitylated proteins
as well as USP9x and Mcl-1.
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The survival of both cell clones depended on Mcl-1 because
down-regulation of Mcl-1 by siRNA resulted in a rapid mitochondrial
permeabilization and thus in cell death. We, therefore, concluded that
the failure of efficient Mcl-1 down-regulation was probably responsi-
ble for enhanced survival or the IR-resistant cells following irradiation.
Those results support an earlier observation that IR-induced deple-
tion of Mcl-1 correlated with radiation-induced apoptosis [28]. Other
experiment, however, indicate that apoptosis can proceed without
Mcl-1 degradation [29]. Thus, we cannot exclude the involvement
of other factors controlling the radiosensitivity in Jurkat cells.
Many tumors exceedingly overexpress Mcl-1 and fail to down-
regulate the protective protein in response to single drug treatment,
underlining the importance to reduce Mcl-1 half-life time to increase
therapeutic success [30,31]. We detected decreased Mcl-1 turnover in
sensitive Jurkat cells 24 hours after irradiation, whereas Mcl-1 half-life
time was not significantly changed in resistant cells. Several possible
mechanisms controlling Mcl-1 stability were described so far includ-
ing the binding to BH3-only proteins, phosphorylation by kinases,
and the regulation of its ubiquitylation status by ubiquitin ligases
and deubiquitinases.
Regulation of Mcl-1 Stability and Radioresistance by BH3-only
Proteins and Ubiquitin Ligases
Several recent publications indicate that BH3-only proteins Bim,
Puma, and Noxa can destabilize Mcl-1 [11,13,32]. All three proteins
are important mediators of radiation-induced apoptosis [33–35].
The mechanism is thought to involve the tumor suppressor p53 that
upregulates the transcription of Bim, Puma, and Noxa in response to
IR-induced DNA damage [33,35–38]. However, because of a mutation,
Jurkat cells do not express p53 [39], thus an up-regulation of Bim, Puma,
and Noxa was not observed in response to IR. Interestingly, Jurkat cells
express the three BH3-only proteins even when not irradiated. Thus, a
p53-independent mechanism has to regulate the expression of Bim, Puma,
and Noxa in Jurkat cells. Although involved in IR-induced apoptosis in
Figure 7. Depletion of USP9x enhances radiation-induced Mcl-1 degradation. Nontargeting (nt; 1 μM) or USP9x-targeting (usp9x) siRNA
was electroporated into IR-sensitive and IR-resistant cells. (A) Forty-eight hours later, down-regulation of USP9x and Mcl-1 levels were
examined by Western blot and quantified by densitometry. USP9x knockdown has no effect on Mcl-1 levels. (B–F) Forty-eight hours after
electroporation, cells were irradiated with 10 Gy. ΔΨm dissipation (B) and DNA fragmentation (C) were measured 24 and 48 hours after
irradiation, respectively. Down-regulation of USP9x slightly enhanced radiation-induced ΔΨm dissipation and DNA degradation in IR-
sensitive cells. The sensitization was even greater in IR-resistant cells. Flow cytometric data show means ± SD (n = 6). *P < .05,
**P < .01, ***P < .001; NS indicates no significance. (D) Forty-eight hours after electroporation, cells were irradiated with 10 Gy. Cells
were lysed at indicated times after irradiation. Mcl-1 levels as well as caspase-3 and PARP processing were analyzed by Western blot. In
addition, Mcl-1 levels were quantified by densitometry. IR-induced Mcl-1 decline, caspase-3 (C3), and PARP processing were clearly
accelerated by USP9x silencing in IR-resistant cells 30 hours after irradiation (right panel). USP9x silencing in IR-sensitive cells did
not alter Mcl-1 decline, caspase-3, and PARP processing 24 hours after irradiation (left panel). (E–G) Forty-eight hours after irradiation
with 10 Gy, IR-resistant cells transfected with nt or usp9x siRNA were treated with 1 μM cycloheximide for 0 to 3 hours. Cells were lysed
at respective time points. (E) Mcl-1 levels were analyzed by Western blot. (F) Mcl-1 levels were quantified by densitometry. The values
were fitted and the half-life of Mcl-1 was calculated. (G) Graph shows the mean values ± SD of Mcl-1 half-life time (n = 4).
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several cell types, knockdown experiments show that none of the three
BH3-only proteins is essential for IR-induced apoptosis in Jurkat
cells. In addition, we have shown that none of the proteins affects
Mcl-1 levels. Thus, regulation of Mcl-1 levels by ubiquitin ligase Mule
that competitively binds to Noxa is also very unlikely. Taken together,
our results suggest that the BH3-only proteins do not regulate Mcl-1
stability and Jurkat cell survival upon irradiation.
Previous studies repeatedly reported that phosphorylation of Mcl-1
by GSK-3β can enhance its ubiquitylation and proteasomal degrada-
tion [16–18]. However, inhibition of GSK-3β did not change Mcl-1
levels or sensitivity to IR-induced apoptosis. Moreover, IR-induced
phosphorylation of Mcl-1 could not be detected (see Figure W1).
Although phosphorylation of Mcl-1 can accelerate its degradation,
it is not essential for β-TrCP– or FBW7-dependent Mcl-1 degrada-
tion [16,18]. Thus, Skip/Collin/F-box ubiquitin ligases containing
specific Mcl-1–recognizing components, such as β-TrCP or FBW7,
might still control Mcl-1 turnover in Jurkat cells. Further experiments
are needed to resolve the role of ubiquitin ligases in Mcl-1 degradation
and radiosensitivity.
Regulation of Mcl-1 Stability by Deubiquitinases
Poly-ubiquitin chains can be removed from proteins by deubiqui-
tinases, thereby preventing proteasomal degradation and stabilizing
protein levels. A recent publication by Schwickart et al. has shown
that down-regulation of USP9x increased the sensitivity to apoptosis
induced by the Bcl-2 inhibitor ABT-737 and delayed tumor growth
in xenograft mouse model [20]. From these experiments, Schwickart
et al. concluded that the Mcl-1 turnover rate and tumor growth
depended on USP9x expression. Our results indicate that changed
Mcl-1 turnover is also responsible for altered responsiveness to IR.
The radiosensitive and radioresistant Jurkat cells, however, expressed
similar amounts of USP9x. Thus, the mere USP9x expression cannot
explain the difference in radiosensitivity. However, radiosensitivity
clearly depended on USP9x, because down-regulation of USP9x by
siRNA increased radiosensitivity in the IR-resistant Jurkat and K562
cells. In contrast to earlier observations made by Schwickart et al.,
USP9x knockdown did not significantly change Mcl-1 protein levels
or its turnover rate in nonirradiated cells. However, Mcl-1 half-life
time was greatly reduced after irradiation when USP9x was silenced
in the resistant subclone. The accelerated Mcl-1 decline correlates
with enhanced apoptosis induction. Obviously, USP9x is an impor-
tant factor that maintains Mcl-1 stability and survival upon irradia-
tion. IR reduced also the half-life time of Mcl-1 in resistant cells
transfected with nontargeting siRNA, although only slightly and
not significantly. This indicates that, apart from USP9x, other fac-
tors contribute to Mcl-1 protein stability. This assumption is also
Figure 8. Silencing of USP9x accelerates Mcl-1 decline and apoptosis in IR-resistant K562 cells. K562 leukemic cells were irradiated with
10 Gy. (A) Cells were lysed 24 and 48 hours after irradiation. Western blot analysis shows weak caspase-9 (C9), caspase-3 (C3), and
PARP cleavage, as well as Mcl-1 depletion, 48 hours after irradiation. (B) Flow cytometric analysis of DNA fragmentation indicates very
moderate apoptosis induction within the first 48 hours after irradiation, which increased 72 hours after irradiation. (C, D) siRNA (1 μM)
was electroporated into K562 cells. Forty-eight hours after electroporation, cells were irradiated with 10 Gy. (C) DNA fragmentation was
analyzed 48 and 72 hours after irradiation. (D) Lysates were made 30 and 48 hours after irradiation. Down-regulation of USP9x enhanced
Mcl-1 decline, as well as caspase-3 (C3) and PARP processing, 48 hours after irradiation. Flow cytometric data showmeans ± SD (n= 6).
*** indicates high significance (P < .001); NS indicates no significance.
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supported by Western blot analysis of IR-resistant Jurkat and K562
cells. Despite an excellent down-regulation of USP9x, IR-induced
Mcl-1 decrease and caspase-3 activation did not occur to the same
extent as in IR-sensitive Jurkat cells.
In the present study, we provide a link between USP9x activity,
Mcl-1 stability, and radiosensitivity. USP9x becomes activated only
in the resistant subclone 24 hours after IR and coincides with less
ubiquitylated Mcl-1. In addition, USP9x precipitated from irradiated
resistant cells was able to deubiquitylate Mcl-1 in vitro. Interestingly,
IR-induced accumulation of ubiquitylated proteins in whole-cell lysates
was not observed. Therefore, our results suggest a specific regulation of
Mcl-1 protein levels in response to IR rather than a global shutdown of
protein degradation.
So far nothing is known about the regulation of USP9x activity.
USP9x becomes phosphorylated in response to IR (Figure W1A).
Phosphorylation is often associated with changed enzymatic activ-
ity. Indeed, phosphorylation of USP9x correlated with enzymatic
activity in irradiated Jurkat cells, but a direct link between phosphor-
ylation and USP9x activation remains to be shown.
Taken together, we identified the deubiquitinase USP9x as a novel
factor mediating radioresistance, which was activated in resistant cells
upon irradiation and inhibited apoptosis induction by stabilizing
Mcl-1 levels.
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Figure W1. Irradiation induces phosphorylation of USP9x but not
of Mcl-1. IR-sensitive and IR-resistant Jurkat cells were irradiated
with 10 Gy. Twenty-four hours after irradiation, cells were lysed.
(A) USP9x or (B) Mcl-1 was precipitated from the lysates. Using
a phospho-Ser/Thr–specific antibody, radiation-induced phosphor-
ylation of USP9x is detected byWestern blot. IR-induced phosphor-
ylation of USP9x is much higher in irradiated IR-resistant cells than
IR-sensitive cells. In contrast, no phosphorylation of Mcl-1 could be
detected. The star indicates an unspecific cross reactivity of the
anti–phospho-Ser/Thr antibody with the rabbit antibody used to
precipitate Mcl-1.
